$INBX
Inhibrx Biosciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is INBX down today? It is at $99.15 (-2.30%), and our scanner flagged it 17 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INBX spikes, and full due diligence on INBX — key stats, earnings, dilution and insider activity. Free.
Get free $INBX alerts the moment volume spikes
Our scanner flagged $INBX 17 times in the last 30 days. Create a free account to track $INBX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $99.15
- Change today
- -2.30%
- Previous close
- $101.48
- 52-week range
- $23.77 – $155.29
- Market cap
- $1.39B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 3.3M ▼ -3% vs prior · as of 2026-07-31
- Days to cover
- 15.6d
- Avg daily volume
- 315K
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.7x
- 15m
- 0.7x
- 1h
- 0.8x
- 1D
- 0.4x
Get free INBX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $INBX down today?
INBX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on INBX today, peaking at 10.0x its normal volume.
Likely catalystInhibrx Reports Second Quarter 2026 Financial ResultsReported Net Loss. Net loss was $36.7 million during the second quarter of 2026, or $2.34 per share, basic and diluted, as compared to a net loss of $28.7 million during the second quarter of 2025, or $1.85 per share, basic and diluted., from an SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
7 open-market buys0 buys, 0 sells last 3 months (0/1 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Viking Global Investors Lp Beneficial Owner (10%) | Sold (automatic/other) | -350K 2.4% of company | sold 20% | 1.44M | $11.3M at $32.25 | Oct 7, 25 |
Kayyem Jon Faiz Director | Sold (automatic/other) | -90K 0.6% of company | sold 7.8% | 1.06M | n/a | Mar 27, 25 |
Kayyem Jon Faiz Director | Sold (automatic/other) | -500K 3.4% of company | sold 50% | 509K | n/a | Dec 16, 24 |
Kayyem Jon Faiz Director | Acquired (grant/award) | +500K 3.4% of company | added 77% | 1.15M | n/a | Dec 16, 24 |
Kayyem Jon Faiz Director | Sold (automatic/other) | -52K 0.4% of company | sold 4.3% | 1.15M | n/a | Dec 6, 24 |
Kayyem Jon Faiz Director | Bought (open market) | +38K 0.3% of company | added 37% | 140K | $532K at $14.19 | Nov 20, 24 |
Kayyem Jon Faiz Director | Bought (open market) | +70K 0.5% of company | n/a | 51K | $992K at $14.23 | Nov 19, 24 |
Vuori Kristiina Md Director | Bought (open market) | +7K 0.05% of company | added 48% | 20K | $100K at $15.00 | Oct 3, 24 |
Lappe Mark Officer | Bought (open market) | +13K 0.09% of company | added 1.4% | 925K | $223K at $17.13 | Sep 16, 24 |
Lappe Mark Officer | Bought (open market) | +27K 0.2% of company | added 4.1% | 693K | $406K at $15.05 | Sep 12, 24 |
Vuori Kristiina Md Director | Bought (open market) | +6K 0.04% of company | added 88% | 14K | $97K at $15.07 | Sep 11, 24 |
Lappe Mark Officer | Bought (open market) | +9K 0.06% of company | added 1.0% | 885K | $129K at $15.19 | Sep 10, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $INBX. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$INBX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$INBX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to INBX
Comparable names in biological products, (no diagnostic substances), closest in size first.
INBX stock FAQ
Why is $INBX down today?
INBX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on INBX today, peaking at 10.0x its normal volume.
What is the INBX stock price today?
INBX last traded at $99.15, down 2.30% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live INBX alerts?
The INBX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INBX 17 times in the last 30 days.
What exchange is INBX on?
INBX (Inhibrx Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $1.39B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is INBX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INBX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.